Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[(18)F]-fluorodeoxyglucose-positron emission tomography in patients with active myelopathy.
Functioning assessment vs. conventional medical assessment: a comparative study on health professionals' clinical decision-making and the fit with patient's own perspective of health.
[Anesthetic management of a Dialysis Patient with Chronic Inflammatory Demyelinating Polyneuropathy].
MOG transmembrane and cytoplasmic domains contain highly stimulatory T-cell epitopes in MS.
Wheelchair design for people with neuromuscular disability.
A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
Switching Therapies in Multiple Sclerosis.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Clinical neurophysiology of multiple sclerosis.
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review.
Expanding spectrum of neurologic manifestations in patients with NLRP3 low-penetrance mutations.
Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton.
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
Level of mobility limitations and falls status in persons with multiple sclerosis.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
The Promoter SNP, but not the Alternative Splicing SNP, is Linked to Multiple Sclerosis Among Jordanian Patients.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Obturator neurolysis using 65% alcohol for adductor muscle spasticity.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »